MARKET

PEN

PEN

Penumbra Inc
NYSE
320.91
+0.14
+0.04%
Closed 19:30 11/13 EST
OPEN
322.00
PREV CLOSE
320.77
HIGH
322.00
LOW
320.63
VOLUME
237.59K
TURNOVER
--
52 WEEK HIGH
362.41
52 WEEK LOW
262.94
MARKET CAP
12.65B
P/E (TTM)
80.80
1D
5D
1M
3M
1Y
5Y
1D
Penumbra (PEN) Gets a Hold from UBS
TipRanks · 3d ago
Weekly Report: what happened at PEN last week (1102-1106)?
Weekly Report · 6d ago
Penumbra (PEN), Why Is Its Latest Update Drawing Attention?
Simply Wall St · 11/08 13:33
How Third Quarter Earnings Will Impact Penumbra Stock Investors
Simply Wall St · 11/06 07:31
Weekly Report: what happened at PEN last week (1026-1030)?
Weekly Report · 11/02 09:31
Penumbra (PEN) Reports Q3 Growth And FDA Clearance, Is The Upside Already Priced In?
Simply Wall St · 11/01 12:31
Penumbra (PEN) Q3 Results Spotlight Profit Pressure Beneath Premium Valuation
Simply Wall St · 10/31 00:30
Did FDA Clearance For DVT Treatment Just Shift Penumbra (PEN) Investment Narrative?
Simply Wall St · 10/30 06:40
More
About PEN
Penumbra, Inc. is a thrombectomy company, which is focused on developing technologies for challenging medical conditions, such as ischemic stroke, venous thromboembolism, such as pulmonary embolism, and acute limb ischemia. The Company's broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe. It focuses on developing, manufacturing and marketing novel products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. Some of the conditions it focuses on are Pulmonary Embolism, Deep Vein Thrombosis, Acute Limb Ischemia, Ischemic Stroke, Acute Coronary Syndrome, and Clot associated with Arteriovenous Graft or Fistula. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada, Australia and Singapore, as well as through distributors in select international markets.

Webull offers Penumbra Inc stock information, including NYSE: PEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PEN stock methods without spending real money on the virtual paper trading platform.